New York, New York, United States In 1980 was created Kinled Holding, which is appeared as VC. The leading representative office of defined VC is situated in the New York. The fund was located in North America if to be more exact in United States.
For fund there is no match between the country of its foundation and the country of its the most frequent investments - Switzerland. We can highlight the next thriving fund investment areas, such as Chemical, Crowdfunding. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. The fund has no exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight KB Medical, System1 Biosciences.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Kinled Holding, startups are often financed by Foundation for Technological Innovation (FIT), Venture Kick, Northwell Ventures. The meaningful sponsors for the fund in investment in the same round are Telor International, Northwell Ventures, KREAXI. In the next rounds fund is usually obtained by Telor International.
The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2016. Despite it in 2019 the fund had an activity. Considering the real fund results, this VC is 30 percentage points more often commits exit comparing to other organizations. The higher amount of exits for fund were in 2017. Deals in the range of 1 - 5 millions dollars are the general things for fund. This Kinled Holding works on 12 percentage points less the average amount of lead investments comparing to the other organizations.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Aligned Climate Capital | New York, New York, United States |
| Chenghe Capital | China, Hangzhou, Zhejiang |
| Conexus Credit Union | Canada, Regina, Saskatchewan |
| Entrepia Ventures | California, Santa Clara, United States |
| Financial 360 Investment | - |
| Forebright Capital | China, Guangdong, Shenzhen |
| Four Seasons Ventures | District of Columbia, United States, Washington |
| GF Capital Management & Advisors | New York, New York, United States |
| IHH Healthcare Berhad | Kuala Lumpur, Malaysia |
| Jacobson Family Investments | New York, New York, United States |
| Life Science Institute | Japan, Tokyo |
| Shenzhenshi Xiaohe Chuangye Touzi | China, Guangdong, Shenzhen |
| Tech Equity Partners | Canada, Halifax, Nova Scotia |
| The Next Big Thing Foundation | British Columbia, Canada, Vancouver |
| Udtara Ventures | Delhi, India, New Delhi |
| University of Surrey | Guildford, Surrey, United Kingdom |
| VIC Technology Venture Development | Arkansas, Fayetteville, United States |
| WaterEquity | Kansas City, Missouri, United States |
| ZenShin Capital | California, Menlo Park, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Nanoflex Robotics AG. | $12M | 10 Feb 2023 | Zürich, Zurich, Switzerland | ||
PreComb Therapeutics AG | $1M | 04 Oct 2022 | Hombrechtikon, Zurich, Switzerland | ||
Opal | $5M | 01 Jan 2022 | Paris, Ile-de-France, France | ||
Alentis Therapeutics | $65M | 15 Jun 2021 | Basel, Basel-City, Switzerland | ||
Hummingbird Bioscience | $125M | 18 May 2021 | Singapore, Central Region, Singapore | ||
PreComb Therapeutics AG | $2M | 26 Apr 2021 | Hombrechtikon, Zurich, Switzerland | ||
Eirion Therapeutics | $40M | 09 Mar 2021 | Woburn, Massachusetts, United States | ||
Muse Finance | $1M | 11 Feb 2021 | London, England, United Kingdom | ||
Corlieve Therapeutics | 02 Nov 2020 | Paris, Ile-de-France, France |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Nanoflex Robotics AG. | $12M | 10 Feb 2023 | Zürich, Zurich, Switzerland | ||
PreComb Therapeutics AG | $1M | 04 Oct 2022 | Hombrechtikon, Zurich, Switzerland | ||
Opal | $5M | 01 Jan 2022 | Paris, Ile-de-France, France | ||
Alentis Therapeutics | $65M | 15 Jun 2021 | Basel, Basel-City, Switzerland | ||
Hummingbird Bioscience | $125M | 18 May 2021 | Singapore, Central Region, Singapore | ||
PreComb Therapeutics AG | $2M | 26 Apr 2021 | Hombrechtikon, Zurich, Switzerland | ||
Eirion Therapeutics | $40M | 09 Mar 2021 | Woburn, Massachusetts, United States | ||
Muse Finance | $1M | 11 Feb 2021 | London, England, United Kingdom | ||
Corlieve Therapeutics | 02 Nov 2020 | Paris, Ile-de-France, France |
